LIVN LivaNova PLC

75.93USD+1.33%Mkt Cap: 4.18B $P/E: 22.46

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulm…

Key Statistics

Company
Market Cap4.18B USD
Enterprise Value3.96B USD
Revenue (TTM)1.47B USD
Gross Profit939.87M USD
Net Income (TTM)-242.47M USD
Revenue/Share26.89 USD
Last Price75.93 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.3K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)22.46
P/E (Forward)16.00
PEG0.93
EV/EBITDA15.24
EV/Revenue2.69
P/S2.81
P/B3.11
EPS (TTM)3.38
EPS (Forward)4.68
52W Range
48.8273% of range85.76
52W High85.76 USD
52W Low48.82 USD
Profitability
Gross Margin67.71%
Oper. Margin13.54%
EBITDA Margin17.68%
Profit Margin-17.47%
ROE-20.21%
ROA-9.30%
Growth
Revenue Growth10.80%
Earnings Growth287.80%
Cash Flow & Leverage
Operating CF254.34M USD
CapEx (TTM)81.05M USD
FCF Margin4.07%
FCF Yield1.43%
Net Debt-164.67M USD
Net Debt/EBITDA-0.63
Balance Sheet
Debt/Equity0.36
Current Ratio1.45
Quick Ratio1.08
Book Value/Sh24.07 USD
Cash/Share9.38 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)89.10 USD
Upside (mean)+17.3%
Target Range75.00 USD – 100.00 USD
75.00+17.3% to mean100.00
# Analysts10
Ownership
Shares Out.55.09M
Float54.84M
Insiders0.41%
Institutions112.89%
Short Interest
Short Ratio9.5d
Short % Float11.20%
Short % Out.9.76%
Shares Short5.38M
Short (prev mo.)4.72M
Technical
SMA 5079.19 (-4.1%)
SMA 20071.42 (+6.3%)
Beta0.88
S&P 52W Chg15.78%
Avg Vol (30d)632.05K
Avg Vol (10d)689.91K
Technical Indicators
RSI (14)44.1
MACD-1.1199
MACD Signal-0.9653
MACD Hist.-0.1546
BB Upper80.90 USD
BB Middle77.39 USD
BB Lower73.87 USD
BB Width9.09%
ATR (14)2.270 USD
Vol Ratio (20d)1.07x